Amantadine

Amantadine

SCHEMBL7399508

C[C@H](CS)C(=O)O[C@@H](CSc1ccsc1)C(=O)O.NC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BM

The experimentally established mechanism targets of Amantadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.34
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MME P08473 2/20 0.31
SLC1A3 P43003 2/20 0.30
SLC1A2 P43004 2/20 0.30
SLC1A1 P43005 2/20 0.30
KDM4E B2RXH2 1/20 0.30
GLA P06280 1/20 0.30
GAA P10253 1/20 0.30
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amantadine SCHEMBL9298521 1.00 HSD11B1 (0.34) HSD11B1ALDH1A1MEN1KMT2AMME
Amantadine SCHEMBL7394662 0.88 MTNR1A (0.34) ALDH1A1KMT2AKDM4E
Amantadine SCHEMBL7398747 0.88 MTNR1A (0.34) ALDH1A1KMT2AKDM4E
Amantadine SCHEMBL7394660 0.88 MTNR1A (0.34) ALDH1A1KMT2AKDM4E
SCHEMBL7393328 0.87 MME (0.39) ALDH1A1MMESLC1A3SLC1A2SLC1A1
SCHEMBL9240332 0.87 MME (0.39) ALDH1A1MMESLC1A3SLC1A2SLC1A1
Amantadine SCHEMBL7396700 0.84 PTGER1 (0.36) HSD11B1ALDH1A1KMT2A
Amantadine SCHEMBL7396703 0.84 PTGER1 (0.36) HSD11B1ALDH1A1KMT2A
SCHEMBL7399507 0.83 HSD11B1 (0.35) HSD11B1ALDH1A1MEN1KMT2AMME
Amantadine SCHEMBL7389647 0.81 THRB (0.35) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0535042-B1 ANGIOTENSIS CONVERTING ENZYME INHIBITORS FISONS PLC (GB) 1995-03-29 EP disclosed
US-5348978-A Angiotensin converting enzyme inhibitors FISONS PLC (GB) 1994-09-20 US disclosed
EP-0535042-A1 ANGIOTENSIS CONVERTING ENZYME INHIBITORS. FISONS PLC (GB) 1993-04-07 EP disclosed
WO-1992000276-A2 ANGIOTENSIS CONVERTING ENZYME INHIBITORS FISONS PLC (GB) 1992-01-09 WO disclosed